infohep
Interferon- and ribavirin- free treatment using sofusbuvir, ledipasvir and a third direct acting drug for as little as six weeks can cure most previously untreated people with genotype 1 hepatitis C virus (HCV), including those with traditional predictors of poor response.
28 Mar 2014Shorter treatment is possible for hard-to-treat patients
Simeprevir – new HCV protease inhibitor
AbbVie '3D' combination highly potent treatment for genotype 1b infection
European policy
Share this on: